Prescription Rejections for Specialty Oral Anticancer Medications
A study reveals high rejection rates for cancer medications in Medicare and commercial insurance, highlighting the need for streamlined prior authorization processes.
A study reveals high rejection rates for cancer medications in Medicare and commercial insurance, highlighting the need for streamlined prior authorization processes.
California's Assembly Bill 1682 mandates insurance coverage for scalp cooling devices, improving access for chemotherapy patients. Learn more about its impact!
The FDA’s approval of Rasonque for pancreatic cancer alters health insurance dynamics, emphasizing coverage needs for high-cost therapies. Explore the implications.
Explore the implications of optimizing cancer drug dosages on costs, patient care, and the pharmaceutical industry in this in-depth analysis of ongoing research and challenges.
Explore ASCO's advocacy efforts to secure Medicaid access and monitor health legislation impacting cancer patients in 2026. Stay informed on key changes.
Discover the new scalp cooling service for chemotherapy patients at WVU Cancer Institute, improving their comfort and reducing hair loss during treatment.
Explore groundbreaking cancer therapy outcomes for Medicare patients, highlighting pivotal studies on leukemia, lymphoma, and innovative treatments.
Study highlights the limited access of Medicare Advantage beneficiaries to oncology networks, revealing significant disparities in cancer care availability and outcomes.
Discover significant healthcare advancements in Florida, the challenges faced by health insurance market, and impact of philanthropic contributions on patient care.
Explore Carolyn Shay's journey with cancer and how the HealthWell Foundation provides vital financial assistance for treatment and support, improving healthcare accessibility.